Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I, Randomised, Double-blind, Parallel-group, Single-centre Comparative Study to Evaluate the Pharmacodynamic Profile of Dysport, Botox, and Xeomin in the Extensor Digitorum Brevis (EDB) Model in Healthy Adult Male Participants

Next Previous
X
Search
Trial Profile

A Phase I, Randomised, Double-blind, Parallel-group, Single-centre Comparative Study to Evaluate the Pharmacodynamic Profile of Dysport, Botox, and Xeomin in the Extensor Digitorum Brevis (EDB) Model in Healthy Adult Male Participants

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 05 Aug 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Blepharospasm; Equinus foot deformity; Facial wrinkles; Fissure in ano; Gilles de la Tourette's syndrome; Glabellar lines; Hyperhidrosis; Muscle spasticity; Musculoskeletal disorders; Neurogenic bladder; Overactive bladder; Pain; Spasm; Torticollis; Urinary incontinence; Vulvodynia
  • Focus Pharmacodynamics
  • Sponsors Ipsen

    • Most Recent Events

    • 14 Jun 2022 Status changed from active, no longer recruiting to completed.
    • 22 Mar 2022 Planned End Date changed from 3 Jun 2022 to 6 Jun 2022.
    • 02 Feb 2022 Planned primary completion date changed from 28 Feb 2022 to 10 Mar 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top